12月25日，海普瑞今日收盘10.96元，下跌0.81%，最新市净率1.32。
资金流向方面，12月25日，海普瑞主力资金净流入167.14万元，近5日总体呈流出状态，5日共流出46.85万元。
深圳市海普瑞药业集团股份有限公司是一家从事肝素产业链、生物大分子CDMO和创新药物的投资、开发和商业化的企业。主要产品和服务包括依诺肝素钠制剂、肝素钠和依诺肝素钠原料药，以及大分子药物CDMO服务。本公司是全球产销规模最大、也是我国唯一同时取得美国FDA认证和欧盟CEP认证的肝素钠原料药生产企业。公司作为欧盟依诺肝素生物类似物市场的先驱者，公司已在知名医院以及医学专家中树立了良好的品牌声誉。
最新一期业绩显示，2024年三季报，公司实现营业收入40.69亿元，同比0.14%；净利润7.80亿元，同比444.89%，销售毛利率33.20%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.